Top news of the week: 20.05.2021.
Companies And Industries
Abandoned Trump order on the bioeconomy highlights a path forward for Biden — but with mixed reviews
Trump came remarkably close to shoring up the scattershot way the U.S. regulates the bioeconomy, an executive order obtained by STAT shows.
COVID-19 R&D drives sector’s research spending in Q1
The top 100 public biopharmaceutical companies with market caps greater than $1 billion, and excluding big pharma companies, spent a total of almost $12 billion on R&D in the first quarter ...
Biopharma Execs Address the Challenges of a Post-Pandemic Workplace
If these companies are any indication, it appears that the biopharma industry will be a hybrid of virtual and physical workforces, and with this comes a whole new set of risks.
Biopharma R&D 'surged' in 2020, but trial productivity levels a mixed bag: report
A major global pandemic was not enough to stop surging rates of biopharma research and development, but trial productivity still remains below the long-term average.
Legacies: 60 biopharma pioneers over 60 who helped birth a tech revolution in the making
Over the last couple of months, we've lost two of the most prominent people in biopharma. José Baselga and John Martin achieved wonderful things in their lifetimes, and richly deserved the ...
Nature Biotechnology subscription
Gift subscriptions are available for any of the Nature Research journals. If you use a debit or credit card to pay for Springer Nature subscriptions you may be charged a Foreign …
Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia
Drug licenser LianBio and recently IPO’d autoimmune biotech Landos Biopharma are joining forces to develop and sell two ulcerative colitis and Crohn’s disease assets in China and parts of ...
Biopharma groups pledge vaccine equity | BIO
Everyone’s talking about COVID vaccine equity—but what should we REALLY do to make it happen? We joined a commitment outlining five concrete steps. Meanwhile, we tell you what you need to ...